|
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) |
Wilson C, Huang CC, Shara N, Howard BV, Fleg JL, Henderson JA, Howard WJ, Huentelman H, Lee ET, Mete M, Russell M, Galloway JM, Silverman A, Stylianou M, Umans J, Weir MR, Yeh F, Ratner RE |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Wilson C, Huang CC, Shara N, Howard BV, Fleg JL, Henderson JA, Howard WJ, Huentelman H, Lee ET, Mete M, Russell M, Galloway JM, Silverman A, Stylianou M, Umans J, Weir MR, Yeh F, Ratner RE. Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) Journal of Clinical Lipidology 2010; 4(3): 165-172 Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Antihypertensive Agents /economics /therapeutic use; Blood Pressure /drug effects; Cardiovascular Diseases /prevention & Cholesterol, LDL /blood; Cost-Benefit Analysis; Diabetes Complications /prevention & Diabetes Mellitus, Type 2 /blood /drug therapy /economics /physiopathology; Female; Humans; Hypolipidemic Agents /economics /therapeutic use; Indians, North American; Male; Middle Aged; Quality-Adjusted Life Years; United States; control; control AccessionNumber 22010001818 Date bibliographic record published 04/05/2011 |
|
|
|